Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Costs and Cost Analysis × Breast × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 9 Tamoxifen 9 Docetaxel 9 Capecitabine 9 Exercise 7 pyrotinib 6 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Control Groups 6 Carboplatin 6 Vinorelbine 5 Indocyanine Green 5 pertuzumab 4 exemestane 4 Injections 4 Doxorubicin 4 Anastrozole 4 dalpiciclib 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Fulvestrant 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3 Bevacizumab 3 ferumoxides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05100277 2022-01-06

Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective

Hospital Perola Byington

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡